AbbVie ABBV and AstraZeneca AZN are both global healthcare companies with diversified drug portfolios. Both companies have ...

Processa Pharmaceuticals' stock jumps after Phase 2 data show higher capecitabine exposure without added toxicity in ...

An announcement from Athira Pharma ( ($ATHA) ) is now available. On December 18, 2025, Athira Pharma moved to reshape its portfolio and balance ...

In a remarkable pivot, Athira Pharma has a deal to test a promising breast cancer drug and landed $90 million in upfront ...

Aktis Oncology filed for an initial public offering in the United States on Friday, as stock market listings from the biotech ...

Shares of Processa Pharmaceuticals surged after the company reported positive trial data for a treatment for metastatic breast cancer. The stock more than doubled to $6.87 on Wednesday. Shares are up ...

Discover why Day One Biopharmaceuticals, Inc. is surging with Ojemda's growth, strategic deals, and key 2026 catalysts. Click ...

Investing.com -- Athira Pharma Inc (NASDAQ:ATHA) stock surged 73.4% in premarket trading Thursday after the clinical-stage biopharmaceutical company announced it has acquired global rights to develop ...

The royalty rights Royalty Pharma has acquired are expected to extend through approximately 2041 to 2042 for both therapies, providing the company with a long-term revenue stream from these potential ...

Merck & Co. MRK and Bristol Myers Squibb BMY are leading drugmakers with broad and diverse portfolios and a global footprint. Merck is a pharmaceutical conglomerate with a strong oncology franchise, ...

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and ...

Fennec Pharmaceuticals is a commercial-stage oncology supportive-care company centered on Pedmark/Pedmarqsi. Read why FENC stock is a Buy.